APPLICATION
ANDA077021
TYPE
ANDA
ORIGINAL APPROVAL
2004-11-23
LATEST ACTION
2017-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CILOSTAZOLDiscontinued
CILOSTAZOL 100MG · TABLET · ORAL
Approval history
2017-12-01Manufacturing (CMC) · Supplement 14AP
2016-04-04Labeling · Supplement 13 · standardAP
2008-03-10Labeling · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.